Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DNL.L (DNL) Share Price

There is currently no data for DNL.L

DNL.L (DNL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
See more DNL.L trades

DNL.L (DNL) Share Price History

Time period:
to
Date Open High Low Close Volume
See more DNL.L price history

DNL.L (DNL) Regulatory News

Date Source Headline
2nd Nov 2022 7:00 am RNS Cancellation - Diurnal Group plc
1st Nov 2022 9:20 am RNS DIURNAL SCHEME OF ARRANGEMENT BECOMES EFFECTIVE
1st Nov 2022 8:59 am RNS Notification of major holdings
1st Nov 2022 7:30 am RNS Suspension - Diurnal Group plc
28th Oct 2022 4:52 pm RNS EXERCISE OF OPTIONS
28th Oct 2022 2:22 pm RNS COURT SANCTION OF SCHEME OF ARRANGEMENT
28th Oct 2022 1:26 pm RNS Form 8.3 - Diurnal Group plc
27th Oct 2022 5:30 pm RNS Diurnal Group
24th Oct 2022 9:30 am RNS Form 8.5 (EPT/RI) - Diurnal Group plc
21st Oct 2022 1:17 pm RNS RESULTS OF COURT MEETING AND GENERAL MEETING
See more DNL.L regulatory news

DNL.L (DNL) Share News

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

28th Oct 2022 21:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

21st Oct 2022 21:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

14th Oct 2022 15:48

Read More

Diurnal treatment gets approval from Welsh regulatory body

7th Oct 2022 13:01

(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hyperplasia. Read More

Diurnal annual loss widens despite revenue growth as costs balloon

14th Sep 2022 11:40

(Alliance News) - Diurnal Group PLC on Wednesday reported a widened annual loss as costs, especially on research & development, surged. Read More

See more DNL.L news
FTSE 100 Latest
Value8,474.74
Change-133.74

Login to your account

Forgot Password?

Not Registered